These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 26411937)

  • 1. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T; Naito H
    Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
    Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.
    Watanabe S; Kumazaki S; Kusunoki K; Inoue T; Maeda Y; Usui S; Shinohata R; Ohtsuki T; Hirohata S; Kusachi S; Kitamori K; Mori M; Yamori Y; Oka H
    J Atheroscler Thromb; 2018 May; 25(5):439-453. PubMed ID: 29162773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.
    Naito H; Jia X; Yetti H; Yanagiba Y; Tamada H; Kitamori K; Hayashi Y; Wang D; Kato M; Ishii A; Nakajima T
    Environ Health Prev Med; 2016 Sep; 21(5):368-381. PubMed ID: 27209494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHRSP5/Dmcr rats fed a high-fat and high-cholesterol diet develop disease-induced sarcopenia as nonalcoholic steatohepatitis progresses.
    Yamamoto S; Honma K; Fujii M; Kakimoto M; Kirihara S; Nakayama H; Kitamori K; Sato I; Hirohata S; Watanabe S
    Ann Anat; 2023 Aug; 249():152104. PubMed ID: 37209870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.
    Watanabe S; Kumazaki S; Yamamoto S; Sato I; Kitamori K; Mori M; Yamori Y; Hirohata S
    Int J Exp Pathol; 2018 Dec; 99(6):282-294. PubMed ID: 30680827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.
    Yuan Y; Naito H; Jia X; Kitamori K; Nakajima T
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.
    Yetti H; Naito H; Yuan Y; Jia X; Hayashi Y; Tamada H; Kitamori K; Ikeda K; Yamori Y; Nakajima T
    PLoS One; 2018; 13(2):e0192863. PubMed ID: 29438418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.
    Kitamori K; Naito H; Tamada H; Kobayashi M; Miyazawa D; Yasui Y; Sonoda K; Tsuchikura S; Yasui N; Ikeda K; Moriya T; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 May; 17(3):173-82. PubMed ID: 21853259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet.
    Miyaoka Y; Jin D; Tashiro K; Komeda K; Masubuchi S; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    J Pharmacol Sci; 2017 Jul; 134(3):139-146. PubMed ID: 28673635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study.
    Sonoda K; Kono Y; Kitamori K; Ohtake K; Shiba S; Kasono K; Kobayashi J
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.
    Moriya T; Kitamori K; Naito H; Yanagiba Y; Ito Y; Yamagishi N; Tamada H; Jia X; Tsuchikura S; Ikeda K; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 Nov; 17(6):444-56. PubMed ID: 22407906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5/Dmcr rats.
    Kakimoto M; Fujii M; Sato I; Honma K; Nakayama H; Kirihara S; Fukuoka T; Ran S; Hirohata S; Kitamori K; Yamamoto S; Watanabe S
    J Appl Biomed; 2023 Jun; 21(2):80-90. PubMed ID: 37376883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model.
    Yamamoto S; Sato I; Fukuhama N; Akiyama N; Sakai M; Kumazaki S; Ran S; Hirohata S; Kitamori K; Yamori Y; Watanabe S
    Exp Mol Pathol; 2020 Jun; 114():104437. PubMed ID: 32246926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
    Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A "Western Diet" promotes symptoms of hepatic steatosis in spontaneously hypertensive rats.
    Cartland SP; Tamer N; Patil MS; Di Bartolo BA; Kavurma MM
    Int J Exp Pathol; 2020 Oct; 101(5):152-161. PubMed ID: 32783310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.